We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Partners to Offer Advanced Microscopy and Data Processing Solutions

By LabMedica International staff writers
Posted on 02 May 2011
Two German companies have signed a co-marketing agreement linking their advanced microscopy and software products.

Leica Microsystems GmbH (Wetzlar, Germany) is a leading global manufacturer of optical microscopes, equipment for the preparation of microscopic specimens, and related products. The company manufactures products for applications requiring microscopic imaging, measurement, and analysis. It also offers system solutions in the areas of life science including biotechnology and medicine, as well as the science of raw materials and industrial quality assurance.

The partner company, Definiens (Munich, Germany), is a leading health image intelligence company that develops software solutions for biomedical image analysis, data mining, and clinical decision support. The company's software analyzes images from cell-based assays, whole tissue slides, and full body scans and allows users to correlate this information with data derived from other sources, supporting better decisions in research, diagnostics, and therapy.

Together the two companies will cooperatively market their complementary products and host joint workshops and educational events.

"Definiens and Leica Microsystems share a commitment to developing powerful imaging solutions that help researchers understand biological pathways faster and more accurately," said Thomas P. Heydler, CEO of Definiens. "This partnership will provide Leica customers with access to Definiens' advanced image analysis software, enabling high-content screening that directly aids drug discovery efforts around the world."

"Together with Definiens, we look forward to the opportunity to make highly developed and future-proof high content screening solutions widely available for academic research as well. The combination of high-sensitivity confocal technology, miniaturized sample handling, and reproducible evaluation with optimized data management is a sine qua non among drug discovery strategies and the analysis of their physiological relevance," said Dr. Stefan Traeger, managing director of the life science division of Leica Microsystems.

Related Links:
Leica Microsystems GmbH
Definiens





New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Prefilled Tubes
Prefilled 5.0ml Tubes
New
Immunofluorescence Analyzer
IFA System

Latest BioResearch News

Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
02 May 2011  |   BioResearch

Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing
02 May 2011  |   BioResearch

Innate Immunity Variants Associated With Earlier Breast Cancer in BRCA1 Carriers
02 May 2011  |   BioResearch